Sergey Young

Sergey Young is a longevity investor and entrepreneur who focuses on technologies that extend human lifespan. He founded the Longevity Vision Fund, a $100 million venture capital fund that invests in companies developing life extension technologies. Young serves on the board of the American Federation for Aging Research and advises multiple organizations in the longevity space. He speaks at conferences worldwide about aging research, biotechnology investments, and the potential for humans to live significantly longer lives. His investment portfolio includes companies working on regenerative medicine, artificial intelligence applications in healthcare, and biotechnology solutions for age-related diseases. Young advocates for the idea that aging can be treated as a medical condition rather than an inevitable process. He writes and speaks about his prediction that people alive today could live to 200 years old through advances in medical technology and scientific research.

Readers appreciate Young's accessible explanation of complex longevity science and his practical approach to the topic. Many find his investment background gives credibility to his analysis of which technologies show promise. Readers note that he breaks down scientific concepts into understandable terms without oversimplifying. Some readers criticize the book for being too optimistic about timelines for longevity breakthroughs. Others find certain predictions speculative and question whether the promised technologies will become available as quickly as Young suggests. A few readers mention that the book sometimes reads more like investment advice than scientific analysis. Readers frequently praise Young's comprehensive coverage of different longevity approaches, from supplements and lifestyle changes to cutting-edge medical interventions. However, some find the writing repetitive in places and wish for more detailed scientific evidence to support certain claims about future developments.